DSC Advisors’s Bristol-Myers Squibb BMY Stock Holding History

DSC Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,467	Closed	-$267K	–	99
2022 Q2	$267K	Sell	3,467 -486	-12%	-$37K	0.27%	81
2022 Q1	$289K	Buy	+3,953	New	+$265K	0.1%	95
2021 Q4	–	Sell	-91,763	Closed	-$5.43M	–	72
2021 Q3	$5.43M	Buy	91,763 +10,037	+12%	+$661K	5.51%	6
2021 Q2	$5.46M	Buy	81,726 +14,483	+22%	+$944K	3.94%	7
2021 Q1	$4.25M	Buy	67,243 +6,588	+11%	+$410K	2.63%	8
2020 Q4	$3.76M	Sell	60,655 -249,787	-80%	-$15.4M	3.11%	9
2020 Q3	$4.21M	Buy	310,442 +250,235	+416%	+$15.1M	2.81%	9
2020 Q2	$3.54M	Buy	60,207 +9,887	+20%	+$591K	3.88%	9
2020 Q1	$2.81M	Sell	50,320 -20,919	-29%	-$1.28M	2.74%	11
2019 Q4	$4.57M	Buy	71,239 +70,156	+6,478%	+$4.02M	2.19%	14
2019 Q3	$55K	Buy	+1,083	New	+$50.9K	0.01%	93
2019 Q1	–	Sell	-76,476	Closed	-$3.98M	–	80
2018 Q4	$3.98M	Buy	+76,476	New	+$4.11M	0.48%	20

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSC Advisors's BMY Position: Q3 2022 in Review

DSC Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 3,467 shares — an estimated $267K sold.

DSC Advisors first reported a position in BMY in Q4 2018 and held it in 12 quarters. The position peaked at $5.46M in Q2 2021. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

DSC Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
DSC Advisors sold 3,467 Bristol-Myers Squibb shares in Q3 2022, an estimated $267K.
DSC Advisors first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 12 quarters.
DSC Advisors's Bristol-Myers Squibb position peaked at $5.46M in Q2 2021.
2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on DSC Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.